Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose Results Support Advancement of the Program into Phase 2 Development Combination of Keytruda® and the ...

The agenda for the 25 (th) annual Bio-IT World Conference & Expo highlights the latest advancements in agentic AI, generative AI, federated learning, foundation models, robotics, multimodal data ...

Reviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 3Q:25 results, confirming the pre-new drug application (NDA) meeting with the FDA in 4Q:25 to see if an NDA can be accepted using existing ...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 fourth quarter and full 2025 fiscal year ...

Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling December 3, ...

Though most of the people working there were true believers, there were some who seemed to understand things were not quite ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

Billings Farm & Museum has announced the 16th season of the Woodstock Vermont Film Series, featuring films that celebrate human connection. Films will be screened at 3 ...

Hello, and welcome, everyone, to the Interim Therapeutics Third Quarter 2025 Financial Results. My name is Becky and I will be your operator today. [Operator Instructions]. I will now hand over to ...

Vaccine Was Safe and Well Tolerated at the Maximum Tolerated DoseResults Support Advancement of the Program into Phase 2 DevelopmentCombination of ...

NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ...